[Adverse effects of immune checkpoint inhibitors used to treat melanoma and other cancer]
{{output}}
Monoclonal antibodies targeted against the immune checkpoint molecules CTLA-4 and PD-1 have recently obtained approval for the treatment of metastatic melanoma and advanced/refractory non small-cell lung cancers and metastatic renal cancer. Besides their effic... ...
